細胞計数の世界市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)

細胞計数市場の成長と動向：

世界の細胞計数市場規模は2030年に154億6,000万米ドルに達し、2025年から2030年にかけてCAGR 8.7%で成長すると予測されています。

がん、HIV、アルツハイマーなどの慢性疾患の有病率の上昇が、この業界の成長促進要因となっています。これらの疾患の有病率の増加は臨床研究活動を急増させ、その結果、細胞計数装置と消耗品の需要を促進しています。細胞計数が重要な役割を果たす細胞治療薬の開発を促進する政府の取り組みも、市場の成長見通しを拡大しています。

研究開発を促進するための様々な官民団体との研究機関の共同研究の増加が成長を大きく後押ししています。高品質の標準を確保し、正確な結果の生成を促進するために、公的機関や民間の研究所に対して提案されるガイドラインや推奨事項の数が増加していることが、今後数年間における機器の採用を改善する可能性が高いです。例えば、2021年5月、国際幹細胞研究学会は細胞ベースの治療と研究の開発のためのガイドラインを更新しました。提案されたガイドラインは、研究開発の全段階に焦点を当て、前臨床研究の質を向上させるものです。

これらの装置における技術的進歩もまた、市場の成長見通しを広げています。鑑別細胞計数における有望な技術進歩の一つは、芽球の認識、免疫小板計数、芽球の検出、網状赤血球分画、幹細胞計数をより高い精度で行えるようになったことです。CD4+T細胞計数技術の出現は、免疫応答の指標として非常に有用であることが証明され、抗レトロウイルス療法 (ARV) の成否を評価するために採用されています。CD4＋T細胞およびCD8＋T細胞の計数を行う専用のサイトメーターが市場にあり、例えばBecton Dickinson社のFACSCountはT細胞計数技術に基づいています。

COVID-19のパンデミックは、業界の成長にプラスの影響を与えると予想されています。入院中のCOVID-19患者のWBC数は、患者の死亡と有意な相関関係があります。COVID-19治療では、白血球数が高いほどさらに注意が必要です。COVID-19に罹患した患者における細胞数の重要性の高まりは、パンデミック時の業界の成長を増大させました。

強化されたインフォマティクス・ソリューションや、光学顕微鏡や蛍光顕微鏡のような改良された画像解析機器の開発が、この市場の成長見通しに拍車をかけています。これらの機器は、新興経済諸国に多く見られる低サンプルスループットの検査室やリソースの限られた環境でますます採用されるようになっており、それによって業界の成長余地が広がっています。

一方、熟練した専門家が限られていることが、市場の成長を抑制する重大な要因となっています。熟練プロフェッショナルの不足は、トレーニング施設の不足とトレーニングコストの高さに起因しています。このシナリオを改善するために、業界各社はこれらの企業が開発したソフトウェアのトレーニングプログラムの作成に参加し、医療従事者や研究者に細胞計数ソフトウェアの操作を奨励することが求められています。さらに、これらのソフトウェアツールが標準化されていないことも、ソフトウェアごとにユーザーインターフェースが異なるため、研究者やヘルスケア専門家を制限する上で重要な役割を果たしています。

細胞計数市場：分析概要

• 製品別では、消耗品・付属品セグメントが2024年に54.0%の最大収益シェアを占め、予測期間中に最も速いCAGRで成長すると予測されています。
• マイクロプレートのサブセグメントは、予測期間中に最も速いCAGRで拡大する見込みです。マイクロプレートは通常、極低濃度サンプルの分析に使用されます。マイクロプレートの消費が増加しているのは、汚染を防ぐために新しいサンプルを分析する際に新しいプレートを繰り返し使用する必要があるためです。
• 機器分野では、自動細胞計数装置が予測期間中に指数関数的な成長を遂げると予測されています。検査時間の短縮、エラー発生の低減、オペレーター間のばらつきといった利点により、自動計数装置の需要がさらに高まると予想されます。
• 用途別では、完全血球計数分野が2024年に59.4%の最大収益シェアを占めました。この大きな収益シェアは、血液疾患の発生率の増加に起因しています。
• 最終用途分野では、様々な毒物学的研究の研究開発を促進する政府の取り組みが増加しているため、研究機関や学術機関が2024年に39.8%の最大収益シェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 細胞計数市場：変動要因・傾向・範囲

• 市場連関の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 細胞計数市場：製品別のビジネス分析

• 市場シェア：製品別 (2024年・2030年)
• 製品別ダッシュボード
• 市場規模の予測と動向分析：製品別 (2018～2030年)
• 機器
• 消耗品・付属品

第5章 細胞計数市場：用途別のビジネス分析

• 市場シェア：用途別 (2024年・2030年)
• 用途別ダッシュボード
• 市場規模の予測と動向分析：用途別 (2018～2030年)
• 完全血球計算
• 幹細胞調査
• 細胞ベース治療
• バイオプロセス
• 毒物学
• その他

第6章 細胞計数市場：最終用途別のビジネス分析

• 市場シェア：最終用途別 (2024年・2030年)
• 最終用途別ダッシュボード
• 市場規模の予測と動向分析：最終用途別 (2018～2030年)
• 病院・診断検査室
• 研究・学術機関
• 製薬・バイオテクノロジー企業
• その他

第7章 細胞計数市場：地域別の推定・動向分析

• 市場シェア：地域別 (2024年・2030年)
• 市場ダッシュボード：地域別
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 国別 (2018～2030年)
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別 (2018～2030年)
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 国別 (2018～2030年)
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別 (2018～2030年)
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別 (2018～2030年)
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市場ポジション分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • PerkinElmer
  • BD
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare
  • DeNovix

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global cell counting market, by region, 2018 - 2030 (USD Million)
• Table 4. Global cell counting market, by product, 2018 - 2030 (USD Million)
• Table 5. Global cell counting market, by application, 2018 - 2030 (USD Million)
• Table 6. Global cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 7. North America cell counting market, by country, 2018 - 2030 (USD Million)
• Table 8. North America cell counting market, by product, 2018 - 2030 (USD Million)
• Table 9. North America cell counting market, by application, 2018 - 2030 (USD Million)
• Table 10. North America cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 11. U.S. cell counting market, by product, 2018 - 2030 (USD Million)
• Table 12. U.S. cell counting market, by application, 2018 - 2030 (USD Million)
• Table 13. U.S. Cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 14. Canada cell counting market, by product, 2018 - 2030 (USD Million)
• Table 15. Canada cell counting market, by application, 2018 - 2030 (USD Million)
• Table 16. Canada cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 17. Mexico cell counting market, by product, 2018 - 2030 (USD Million)
• Table 18. Mexico cell counting market, by application, 2018 - 2030 (USD Million)
• Table 19. Mexico cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 20. Europe cell counting market, by country, 2018 - 2030 (USD Million)
• Table 21. Europe cell counting market, by product, 2018 - 2030 (USD Million)
• Table 22. Europe cell counting market, by application, 2018 - 2030 (USD Million)
• Table 23. Europe cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 24. UK cell counting market, by product, 2018 - 2030 (USD Million)
• Table 25. UK cell counting market, by application, 2018 - 2030 (USD Million)
• Table 26. UK Cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 27. Germany cell counting market, by product, 2018 - 2030 (USD Million)
• Table 28. Germany cell counting market, by application, 2018 - 2030 (USD Million)
• Table 29. Germany cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 30. France cell counting market, by product, 2018 - 2030 (USD Million)
• Table 31. France cell counting market, by application, 2018 - 2030 (USD Million)
• Table 32. France Cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 33. Italy cell counting market, by product, 2018 - 2030 (USD Million)
• Table 34. Italy cell counting market, by application, 2018 - 2030 (USD Million)
• Table 35. Italy cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 36. Spain cell counting market, by product, 2018 - 2030 (USD Million)
• Table 37. Spain cell counting market, by application, 2018 - 2030 (USD Million)
• Table 38. Spain cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 39. Norway cell counting market, by product, 2018 - 2030 (USD Million)
• Table 40. Norway cell counting market, by application, 2018 - 2030 (USD Million)
• Table 41. Norway Cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 42. Denmark cell counting market, by product, 2018 - 2030 (USD Million)
• Table 43. Denmark cell counting market, by application, 2018 - 2030 (USD Million)
• Table 44. Denmark cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 45. Sweden cell counting market, by product, 2018 - 2030 (USD Million)
• Table 46. Sweden cell counting market, by application, 2018 - 2030 (USD Million)
• Table 47. Sweden cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific cell counting market, by country, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific cell counting market, by product, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific cell counting market, by application, 2018 - 2030 (USD Million)
• Table 51. Asia Pacific cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 52. Japan cell counting market, by product, 2018 - 2030 (USD Million)
• Table 53. Japan cell counting market, by application, 2018 - 2030 (USD Million)
• Table 54. Japan cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 55. China cell counting market, by product, 2018 - 2030 (USD Million)
• Table 56. China cell counting market, by application, 2018 - 2030 (USD Million)
• Table 57. China cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 58. India cell counting market, by product, 2018 - 2030 (USD Million)
• Table 59. India cell counting market, by application, 2018 - 2030 (USD Million)
• Table 60. India cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 61. Australia cell counting market, by product, 2018 - 2030 (USD Million)
• Table 62. Australia cell counting market, by application, 2018 - 2030 (USD Million)
• Table 63. Australia cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 64. South Korea cell counting market, by product, 2018 - 2030 (USD Million)
• Table 65. South Korea cell counting market, by application, 2018 - 2030 (USD Million)
• Table 66. South Korea cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 67. Thailand cell counting market, by product, 2018 - 2030 (USD Million)
• Table 68. Thailand cell counting market, by application, 2018 - 2030 (USD Million)
• Table 69. Thailand cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 70. Latin America cell counting market, by country, 2018 - 2030 (USD Million)
• Table 71. Latin America cell counting market, by product, 2018 - 2030 (USD Million)
• Table 72. Latin America cell counting market, by application, 2018 - 2030 (USD Million)
• Table 73. Latin America cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 74. Brazil cell counting market, by product, 2018 - 2030 (USD Million)
• Table 75. Brazil cell counting market, by application, 2018 - 2030 (USD Million)
• Table 76. Brazil cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 77. Argentina cell counting market, by product, 2018 - 2030 (USD Million)
• Table 78. Argentina cell counting market, by application, 2018 - 2030 (USD Million)
• Table 79. Argentina cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa Cell counting market, by country, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa cell counting market, by product, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa cell counting market, by application, 2018 - 2030 (USD Million)
• Table 83. Middle East & Africa cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 84. South Africa cell counting market, by product, 2018 - 2030 (USD Million)
• Table 85. South Africa cell counting market, by application, 2018 - 2030 (USD Million)
• Table 86. South Africa cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia cell counting market, by product, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia cell counting market, by application, 2018 - 2030 (USD Million)
• Table 89. Saudi Arabia cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 90. UAE cell counting market, by product, 2018 - 2030 (USD Million)
• Table 91. UAE cell counting market, by application, 2018 - 2030 (USD Million)
• Table 92. UAE cell counting market, by end use, 2018 - 2030 (USD Million)
• Table 93. Kuwait cell counting market, by product, 2018 - 2030 (USD Million)
• Table 94. Kuwait cell counting market, by application, 2018 - 2030 (USD Million)
• Table 95. Kuwait cell counting market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Cell counting market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Product and application outlook (USD Million)
• Fig. 10 End use outlook (USD Million)
• Fig. 11 Competitive landscape
• Fig. 12 Cell counting market dynamics
• Fig. 13 Cell counting market: Porter's five forces analysis
• Fig. 14 Cell counting market: PESTLE analysis
• Fig. 15 Cell counting market: Product segment dashboard
• Fig. 16 Cell counting market: Product market share analysis, 2024 & 2030
• Fig. 17 Instruments market, 2018 - 2030 (USD Million)
• Fig. 18 Spectrophotometers market, 2018 - 2030 (USD Million)
• Fig. 19 Flow cytometers market, 2018 - 2030 (USD Million)
• Fig. 20 Hemocytometer market, 2018 - 2030 (USD Million)
• Fig. 21 Automated cell counters market, 2018 - 2030 (USD Million)
• Fig. 22 Microscopes market, 2018 - 2030 (USD Million)
• Fig. 23 Others market, 2018 - 2030 (USD Million)
• Fig. 24 Consumables & accessories market, 2018 - 2030 (USD Million)
• Fig. 25 Reagents market, 2018 - 2030 (USD Million)
• Fig. 26 Microplates market, 2018 - 2030 (USD Million)
• Fig. 27 Others market, 2018 - 2030 (USD Million)
• Fig. 28 Cell counting market: Application segment dashboard
• Fig. 29 Cell counting market: Application market share analysis, 2024 & 2030
• Fig. 30 Complete blood count market, 2018 - 2030 (USD Million)
• Fig. 31 Automated cell counters market, 2018 - 2030 (USD Million)
• Fig. 32 Manual cell counters market, 2018 - 2030 (USD Million)
• Fig. 33 Stem cell research market, 2018 - 2030 (USD Million)
• Fig. 34 Cell based therapeutics market, 2018 - 2030 (USD Million)
• Fig. 35 Bioprocessing market, 2018 - 2030 (USD Million)
• Fig. 36 Toxicology market, 2018 - 2030 (USD Million)
• Fig. 37 Others market, 2018 - 2030 (USD Million)
• Fig. 38 Cell counting market: End use segment dashboard
• Fig. 39 Cell counting market: End use market share analysis, 2024 & 2030
• Fig. 40 Hospitals & diagnostic laboratories market, 2018 - 2030 (USD Million)
• Fig. 41 Research & academic institutes market, 2018 - 2030 (USD Million)
• Fig. 42 Pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 43 Others market, 2018 - 2030 (USD Million)
• Fig. 44 Cell counting market revenue, by region
• Fig. 45 Regional marketplace: Key takeaways
• Fig. 46 Regional marketplace: Key takeaways
• Fig. 47 North America cell counting market, 2018 - 2030 (USD Million)
• Fig. 48 U.S. country dynamics
• Fig. 49 U.S. cell counting market, 2018 - 2030 (USD Million)
• Fig. 50 Canada country dynamics
• Fig. 51 Canada cell counting market, 2018 - 2030 (USD Million)
• Fig. 52 Mexico country dynamics
• Fig. 53 Mexico cell counting market, 2018 - 2030 (USD Million)
• Fig. 54 Europe cell counting market, 2018 - 2030 (USD Million)
• Fig. 55 UK country dynamics
• Fig. 56 UK cell counting market, 2018 - 2030 (USD Million)
• Fig. 57 Germany country dynamics
• Fig. 58 Germany cell counting market, 2018 - 2030 (USD Million)
• Fig. 59 France country dynamics
• Fig. 60 France cell counting market, 2018 - 2030 (USD Million)
• Fig. 61 Italy country dynamics
• Fig. 62 Italy cell counting market, 2018 - 2030 (USD Million)
• Fig. 63 Spain country dynamics
• Fig. 64 Spain cell counting market, 2018 - 2030 (USD Million)
• Fig. 65 Norway country dynamics
• Fig. 66 Norway cell counting market, 2018 - 2030 (USD Million)
• Fig. 67 Sweden country dynamics
• Fig. 68 Sweden cell counting market, 2018 - 2030 (USD Million)
• Fig. 69 Denmark country dynamics
• Fig. 70 Denmark cell counting market, 2018 - 2030 (USD Million)
• Fig. 71 Asia Pacific cell counting market, 2018 - 2030 (USD Million)
• Fig. 72 Japan country dynamics
• Fig. 73 Japan cell counting market, 2018 - 2030 (USD Million)
• Fig. 74 China country dynamics
• Fig. 75 China cell counting market, 2018 - 2030 (USD Million)
• Fig. 76 India country dynamics
• Fig. 77 India cell counting market, 2018 - 2030 (USD Million)
• Fig. 78 Australia country dynamics
• Fig. 79 Australia cell counting market, 2018 - 2030 (USD Million)
• Fig. 80 South Korea country dynamics
• Fig. 81 South Korea cell counting market, 2018 - 2030 (USD Million)
• Fig. 82 Thailand country dynamics
• Fig. 83 Thailand cell counting market, 2018 - 2030 (USD Million)
• Fig. 84 Latin America cell counting market, 2018 - 2030 (USD Million)
• Fig. 85 Brazil country dynamics
• Fig. 86 Brazil cell counting market, 2018 - 2030 (USD Million)
• Fig. 87 Argentina country dynamics
• Fig. 88 Argentina cell counting market, 2018 - 2030 (USD Million)
• Fig. 89 MEA cell counting market, 2018 - 2030 (USD Million)
• Fig. 90 South Africa country dynamics
• Fig. 91 South Africa cell counting market, 2018 - 2030 (USD Million)
• Fig. 92 Saudi Arabia country dynamics
• Fig. 93 Saudi Arabia cell counting market, 2018 - 2030 (USD Million)
• Fig. 94 UAE country dynamics
• Fig. 95 UAE cell counting market, 2018 - 2030 (USD Million)
• Fig. 96 Kuwait country dynamics
• Fig. 97 Kuwait cell counting market, 2018 - 2030 (USD Million)
• Fig. 98 Company categorization
• Fig. 99 Company market position analysis
• Fig. 100 Strategic framework

Cell Counting Market Growth & Trends:

The global cell counting market size is expected to reach USD 15.46 billion in 2030 and is projected to grow at a CAGR of 8.7% from 2025 to 2030. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer's is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.

An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to growth. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.

Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.

The COVID-19 pandemic is anticipated to positively impact industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.

The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled the growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.

On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to a lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, the lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differ in user interface.

Cell Counting Market Report Highlights:

• By product, consumables and accessories segment accounted for the largest revenue share of 54.0% in 2024 and is expected to grow at the fastest CAGR of during the forecast period
• The microplates sub-segment is poised to expand at the fastest CAGR during the forecast period. Microplates are usually used for analyzing very low concentration samples. The increased consumption of these plates is attributed to the repeated need to use fresh plates for analyzing a new sample to prevent contamination
• In the instruments segment, automated cell counters are anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and inter-operator variability are expected to further increase the demand for automated counters
• By application, the complete blood count segment held the largest revenue share of 59.4% in 2024. The large revenue share can be attributed to increasing incidence of blood disorders
• In the end-use segment, research and academic institutes accounted for the largest revenue share of 39.8% in 2024 owing to growing number of government initiatives focused on promoting R&D in various toxicology studies

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Counting Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Cell Counting Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.4.2. Spectrophotometers
    • 4.4.2.1. Spectrophotometers Market, 2018 - 2030 (USD Million)
  • 4.4.3. Flow Cytometers
    • 4.4.3.1. Flow Cytometers Market, 2018 - 2030 (USD Million)
  • 4.4.4. Hemocytometer
    • 4.4.4.1. Hemocytometer Market, 2018 - 2030 (USD Million)
  • 4.4.5. Automated Cell Counters
    • 4.4.5.1. Automated Cell Counters Market, 2018 - 2030 (USD Million)
  • 4.4.6. Microscopes
    • 4.4.6.1. Microscopes Market, 2018 - 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others Market, 2018 - 2030 (USD Million)
• 4.5. Consumables & Accessories
  • 4.5.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
  • 4.5.2. Reagents
    • 4.5.2.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.5.3. Microplates
    • 4.5.3.1. Microplates Market, 2018 - 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Cell Counting Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Complete Blood Count
  • 5.4.1. Complete Blood Count Market, 2018 - 2030 (USD Million)
  • 5.4.2. Automated Cell Counters
    • 5.4.2.1. Automated Cell Counters Market, 2018 - 2030 (USD Million)
  • 5.4.3. Manual Cell Counters
    • 5.4.3.1. Manual Cell Counters Market, 2018 - 2030 (USD Million)
• 5.5. Stem Cell Research
  • 5.5.1. Stem Cell Research Market, 2018 - 2030 (USD Million)
• 5.6. Cell Based Therapeutics
  • 5.6.1. Cell Based Therapeutics Market, 2018 - 2030 (USD Million)
• 5.7. Bioprocessing
  • 5.7.1. Bioprocessing Market, 2018 - 2030 (USD Million)
• 5.8. Toxicology
  • 5.8.1. Toxicology Market, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Cell Counting Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals & Diagnostic Laboratories
  • 6.4.1. Hospitals & Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
• 6.5. Research & Academic Institutes
  • 6.5.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
• 6.6. Pharmaceutical & Biotechnology Companies
  • 6.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Cell Counting Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Cell Counting Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Cell Counting Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Cell Counting Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Cell Counting Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Cell Counting Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Cell Counting Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Thermo Fisher Scientific Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Merck KGaA
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Agilent Technologies, Inc.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. PerkinElmer
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. BD
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Danaher Corporation
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Bio-Rad Laboratories, Inc.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. GE HealthCare
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. DeNovix
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives